Programma biodefense OpenAI: strategia e rischi

OpenAI launches biodefense program to enhance pandemic preparedness

OpenAI launched a $30M seed investment in biodefense startup Valthos, introduced GPT-Rosalind for drug discovery, and began collaborating with Los Alamos National Laboratory on AI safety in bioscience environments. National lab partnerships and VC flow into AI-driven biodefense signal a maturing market segment where foundation model vendors are positioning for federal contracts in biosecurity.